APO Research
Talk to an analyst

APO RESEARCH · REPORT

Moclobemide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Moclobemide Market Analysis and Forecast 2026-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchMoclobemide Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Moclobemide Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Moclobemide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Moclobemide Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Moclobemide Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Moclobemide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Moclobemide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Moclobemide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Moclobemide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Moclobemide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Moclobemide include Sandoz, Roche, Lunan Pharmaceutical, Viatris, Arrow Pharmaceuticals and Apotex, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Moclobemide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Moclobemide, also provides the sales of main regions and countries. Of the upcoming market potential for Moclobemide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Moclobemide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Moclobemide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Moclobemide sales, projected growth trends, production technology, application and end-user industry.

Moclobemide Segment by Company

Sandoz

Roche

Lunan Pharmaceutical

Viatris

Arrow Pharmaceuticals

Apotex

Moclobemide Segment by Type

150mg

300mg

Moclobemide Segment by Application

Hospital

Clinic

Other

Moclobemide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Moclobemide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Moclobemide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Moclobemide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Moclobemide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Moclobemide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Moclobemide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Moclobemide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 150mg Major Manufacturers Table 3. 300mg Major Manufacturers Table 4. Global Moclobemide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Moclobemide Industry Trends Table 9. Moclobemide Industry Drivers Table 10. Moclobemide Industry Opportunities and Challenges Table 11. Moclobemide Industry Restraints Table 12. Global Moclobemide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Moclobemide Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Moclobemide Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Moclobemide Revenue Market Share by Region (2021-2026) Table 16. Global Moclobemide Revenue Market Share by Region (2027-2032) Table 17. Global Moclobemide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Moclobemide Sales by Region (2021-2026) & (Tons) Table 19. Global Moclobemide Sales by Region (2027-2032) & (Tons) Table 20. Global Moclobemide Sales Market Share by Region (2021-2026) Table 21. Global Moclobemide Sales Market Share by Region (2027-2032) Table 22. Global Moclobemide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Moclobemide Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Moclobemide Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Moclobemide Sales Market Share by Manufacturers (2021-2026) Table 26. Global Moclobemide Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 27. Global Moclobemide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Moclobemide Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Moclobemide Manufacturers, Product Type & Application Table 30. Global Moclobemide Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Moclobemide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Moclobemide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Moclobemide Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Moclobemide Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Moclobemide Revenue Market Share by Type (2021-2026) Table 37. Global Moclobemide Revenue Market Share by Type (2027-2032) Table 38. Global Moclobemide Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 39. Global Moclobemide Sales by Type (2021-2026) & (Tons) Table 40. Global Moclobemide Sales by Type (2027-2032) & (Tons) Table 41. Global Moclobemide Sales Market Share by Type (2021-2026) Table 42. Global Moclobemide Sales Market Share by Type (2027-2032) Table 43. Global Moclobemide Price by Type (2021-2026) & (US$/Kg) Table 44. Global Moclobemide Price by Type (2027-2032) & (US$/Kg) Table 45. Global Moclobemide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Moclobemide Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Moclobemide Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Moclobemide Revenue Market Share by Application (2021-2026) Table 49. Global Moclobemide Revenue Market Share by Application (2027-2032) Table 50. Global Moclobemide Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 51. Global Moclobemide Sales by Application (2021-2026) & (Tons) Table 52. Global Moclobemide Sales by Application (2027-2032) & (Tons) Table 53. Global Moclobemide Sales Market Share by Application (2021-2026) Table 54. Global Moclobemide Sales Market Share by Application (2027-2032) Table 55. Global Moclobemide Price by Application (2021-2026) & (US$/Kg) Table 56. Global Moclobemide Price by Application (2027-2032) & (US$/Kg) Table 57. Sandoz Company Information Table 58. Sandoz Business Overview Table 59. Sandoz Moclobemide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. Sandoz Moclobemide Product Portfolio Table 61. Sandoz Recent Development Table 62. Roche Company Information Table 63. Roche Business Overview Table 64. Roche Moclobemide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 65. Roche Moclobemide Product Portfolio Table 66. Roche Recent Development Table 67. Lunan Pharmaceutical Company Information Table 68. Lunan Pharmaceutical Business Overview Table 69. Lunan Pharmaceutical Moclobemide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. Lunan Pharmaceutical Moclobemide Product Portfolio Table 71. Lunan Pharmaceutical Recent Development Table 72. Viatris Company Information Table 73. Viatris Business Overview Table 74. Viatris Moclobemide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Viatris Moclobemide Product Portfolio Table 76. Viatris Recent Development Table 77. Arrow Pharmaceuticals Company Information Table 78. Arrow Pharmaceuticals Business Overview Table 79. Arrow Pharmaceuticals Moclobemide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Arrow Pharmaceuticals Moclobemide Product Portfolio Table 81. Arrow Pharmaceuticals Recent Development Table 82. Apotex Company Information Table 83. Apotex Business Overview Table 84. Apotex Moclobemide Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Apotex Moclobemide Product Portfolio Table 86. Apotex Recent Development Table 87. North America Moclobemide Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Moclobemide Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Moclobemide Sales by Type (2021-2026) & (Tons) Table 90. North America Moclobemide Sales by Type (2027-2032) & (Tons) Table 91. North America Moclobemide Sales Price by Type (2021-2026) & (US$/Kg) Table 92. North America Moclobemide Sales Price by Type (2027-2032) & (US$/Kg) Table 93. North America Moclobemide Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Moclobemide Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Moclobemide Sales by Application (2021-2026) & (Tons) Table 96. North America Moclobemide Sales by Application (2027-2032) & (Tons) Table 97. North America Moclobemide Sales Price by Application (2021-2026) & (US$/Kg) Table 98. North America Moclobemide Sales Price by Application (2027-2032) & (US$/Kg) Table 99. North America Moclobemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Moclobemide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Moclobemide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Moclobemide Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 103. North America Moclobemide Sales by Country (2021-2026) & (Tons) Table 104. North America Moclobemide Sales by Country (2027-2032) & (Tons) Table 105. North America Moclobemide Sales Price by Country (2021-2026) & (US$/Kg) Table 106. North America Moclobemide Sales Price by Country (2027-2032) & (US$/Kg) Table 107. United States Moclobemide Revenue (2021-2032) & (US$ Million) Table 108. Canada Moclobemide Revenue (2021-2032) & (US$ Million) Table 109. Europe Moclobemide Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Moclobemide Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Moclobemide Sales by Type (2021-2026) & (Tons) Table 112. Europe Moclobemide Sales by Type (2027-2032) & (Tons) Table 113. Europe Moclobemide Sales Price by Type (2021-2026) & (US$/Kg) Table 114. Europe Moclobemide Sales Price by Type (2027-2032) & (US$/Kg) Table 115. Europe Moclobemide Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Moclobemide Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Moclobemide Sales by Application (2021-2026) & (Tons) Table 118. Europe Moclobemide Sales by Application (2027-2032) & (Tons) Table 119. Europe Moclobemide Sales Price by Application (2021-2026) & (US$/Kg) Table 120. Europe Moclobemide Sales Price by Application (2027-2032) & (US$/Kg) Table 121. Europe Moclobemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Moclobemide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Moclobemide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Moclobemide Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 125. Europe Moclobemide Sales by Country (2021-2026) & (Tons) Table 126. Europe Moclobemide Sales by Country (2027-2032) & (Tons) Table 127. Europe Moclobemide Sales Price by Country (2021-2026) & (US$/Kg) Table 128. Europe Moclobemide Sales Price by Country (2027-2032) & (US$/Kg) Table 129. Germany Moclobemide Revenue (2021-2032) & (US$ Million) Table 130. France Moclobemide Revenue (2021-2032) & (US$ Million) Table 131. U.K. Moclobemide Revenue (2021-2032) & (US$ Million) Table 132. Italy Moclobemide Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Moclobemide Revenue (2021-2032) & (US$ Million) Table 134. China Moclobemide Revenue by Type (2021-2026) & (US$ Million) Table 135. China Moclobemide Revenue by Type (2027-2032) & (US$ Million) Table 136. China Moclobemide Sales by Type (2021-2026) & (Tons) Table 137. China Moclobemide Sales by Type (2027-2032) & (Tons) Table 138. China Moclobemide Sales Price by Type (2021-2026) & (US$/Kg) Table 139. China Moclobemide Sales Price by Type (2027-2032) & (US$/Kg) Table 140. China Moclobemide Revenue by Application (2021-2026) & (US$ Million) Table 141. China Moclobemide Revenue by Application (2027-2032) & (US$ Million) Table 142. China Moclobemide Sales by Application (2021-2026) & (Tons) Table 143. China Moclobemide Sales by Application (2027-2032) & (Tons) Table 144. China Moclobemide Sales Price by Application (2021-2026) & (US$/Kg) Table 145. China Moclobemide Sales Price by Application (2027-2032) & (US$/Kg) Table 146. Asia Moclobemide Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Moclobemide Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Moclobemide Sales by Type (2021-2026) & (Tons) Table 149. Asia Moclobemide Sales by Type (2027-2032) & (Tons) Table 150. Asia Moclobemide Sales Price by Type (2021-2026) & (US$/Kg) Table 151. Asia Moclobemide Sales Price by Type (2027-2032) & (US$/Kg) Table 152. Asia Moclobemide Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Moclobemide Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Moclobemide Sales by Application (2021-2026) & (Tons) Table 155. Asia Moclobemide Sales by Application (2027-2032) & (Tons) Table 156. Asia Moclobemide Sales Price by Application (2021-2026) & (US$/Kg) Table 157. Asia Moclobemide Sales Price by Application (2027-2032) & (US$/Kg) Table 158. Asia Moclobemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Moclobemide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Moclobemide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Moclobemide Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 162. Asia Moclobemide Sales by Country (2021-2026) & (Tons) Table 163. Asia Moclobemide Sales by Country (2027-2032) & (Tons) Table 164. Asia Moclobemide Sales Price by Country (2021-2026) & (US$/Kg) Table 165. Asia Moclobemide Sales Price by Country (2027-2032) & (US$/Kg) Table 166. Japan Moclobemide Revenue (2021-2032) & (US$ Million) Table 167. South Korea Moclobemide Revenue (2021-2032) & (US$ Million) Table 168. India Moclobemide Revenue (2021-2032) & (US$ Million) Table 169. Australia Moclobemide Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Moclobemide Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Moclobemide Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Moclobemide Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Moclobemide Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Moclobemide Sales by Type (2021-2026) & (Tons) Table 175. SAMEA Moclobemide Sales by Type (2027-2032) & (Tons) Table 176. SAMEA Moclobemide Sales Price by Type (2021-2026) & (US$/Kg) Table 177. SAMEA Moclobemide Sales Price by Type (2027-2032) & (US$/Kg) Table 178. SAMEA Moclobemide Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Moclobemide Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Moclobemide Sales by Application (2021-2026) & (Tons) Table 181. SAMEA Moclobemide Sales by Application (2027-2032) & (Tons) Table 182. SAMEA Moclobemide Sales Price by Application (2021-2026) & (US$/Kg) Table 183. SAMEA Moclobemide Sales Price by Application (2027-2032) & (US$/Kg) Table 184. SAMEA Moclobemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Moclobemide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Moclobemide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Moclobemide Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 188. SAMEA Moclobemide Sales by Country (2021-2026) & (Tons) Table 189. SAMEA Moclobemide Sales by Country (2027-2032) & (Tons) Table 190. SAMEA Moclobemide Sales Price by Country (2021-2026) & (US$/Kg) Table 191. SAMEA Moclobemide Sales Price by Country (2027-2032) & (US$/Kg) Table 192. Brazil Moclobemide Revenue (2021-2032) & (US$ Million) Table 193. Argentina Moclobemide Revenue (2021-2032) & (US$ Million) Table 194. Chile Moclobemide Revenue (2021-2032) & (US$ Million) Table 195. Colombia Moclobemide Revenue (2021-2032) & (US$ Million) Table 196. Peru Moclobemide Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Moclobemide Revenue (2021-2032) & (US$ Million) Table 198. Israel Moclobemide Revenue (2021-2032) & (US$ Million) Table 199. UAE Moclobemide Revenue (2021-2032) & (US$ Million) Table 200. Turkey Moclobemide Revenue (2021-2032) & (US$ Million) Table 201. Iran Moclobemide Revenue (2021-2032) & (US$ Million) Table 202. Egypt Moclobemide Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Moclobemide Distributors List Table 206. Moclobemide Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Moclobemide Image Figure 2. Global Moclobemide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Moclobemide Market Size Share 2021 VS 2025 VS 2032 Figure 4. 150mg Image Figure 5. 300mg Image Figure 6. Global Moclobemide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Moclobemide Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Moclobemide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Moclobemide Revenue (2021-2032) & (US$ Million) Figure 13. Global Moclobemide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Moclobemide Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Moclobemide Revenue Market Share by Region (2021-2032) Figure 16. Global Moclobemide Sales (2021-2032) & (Tons) Figure 17. Global Moclobemide Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 18. Global Moclobemide Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Moclobemide Sales YoY (2021-2032) & (Tons) Figure 20. Europe Moclobemide Sales YoY (2021-2032) & (Tons) Figure 21. China Moclobemide Sales YoY (2021-2032) & (Tons) Figure 22. Asia (Excluding China) Moclobemide Sales YoY (2021-2032) & (Tons) Figure 23. South America, Middle East and Africa Moclobemide Sales YoY (2021-2032) & (Tons) Figure 24. Global Moclobemide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Moclobemide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Moclobemide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Moclobemide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Moclobemide Revenue Market Share by Type (2021-2032) Figure 30. Global Moclobemide Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 31. Global Moclobemide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Moclobemide Sales Market Share by Type (2021-2032) Figure 33. Global Moclobemide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Moclobemide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Moclobemide Revenue Market Share by Application (2021-2032) Figure 36. Global Moclobemide Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Moclobemide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Moclobemide Sales Market Share by Application (2021-2032) Figure 39. North America Moclobemide Revenue Share by Type (2021-2032) Figure 40. North America Moclobemide Sales Share by Type (2021-2032) Figure 41. North America Moclobemide Revenue Share by Application (2021-2032) Figure 42. North America Moclobemide Sales Share by Application (2021-2032) Figure 43. North America Moclobemide Revenue Share by Country (2021-2032) Figure 44. North America Moclobemide Sales Share by Country (2021-2032) Figure 45. Europe Moclobemide Revenue Share by Type (2021-2032) Figure 46. Europe Moclobemide Sales Share by Type (2021-2032) Figure 47. Europe Moclobemide Revenue Share by Application (2021-2032) Figure 48. Europe Moclobemide Sales Share by Application (2021-2032) Figure 49. Europe Moclobemide Revenue Share by Country (2021-2032) Figure 50. Europe Moclobemide Sales Share by Country (2021-2032) Figure 51. China Moclobemide Revenue Share by Type (2021-2032) Figure 52. China Moclobemide Sales Share by Type (2021-2032) Figure 53. China Moclobemide Revenue Share by Application (2021-2032) Figure 54. China Moclobemide Sales Share by Application (2021-2032) Figure 55. Asia Moclobemide Revenue Share by Type (2021-2032) Figure 56. Asia Moclobemide Sales Share by Type (2021-2032) Figure 57. Asia Moclobemide Revenue Share by Application (2021-2032) Figure 58. Asia Moclobemide Sales Share by Application (2021-2032) Figure 59. Asia Moclobemide Revenue Share by Country (2021-2032) Figure 60. Asia Moclobemide Sales Share by Country (2021-2032) Figure 61. SAMEA Moclobemide Revenue Share by Type (2021-2032) Figure 62. SAMEA Moclobemide Sales Share by Type (2021-2032) Figure 63. SAMEA Moclobemide Revenue Share by Application (2021-2032) Figure 64. SAMEA Moclobemide Sales Share by Application (2021-2032) Figure 65. SAMEA Moclobemide Revenue Share by Country (2021-2032) Figure 66. SAMEA Moclobemide Sales Share by Country (2021-2032) Figure 67. Moclobemide Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Moclobemide Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg
  • 300mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Sandoz
  • Roche
  • Lunan Pharmaceutical
  • Viatris
  • Arrow Pharmaceuticals
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Moclobemide Market by Type
  3. 1.2.1 Global Moclobemide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 150mg
  5. 1.2.3 300mg
  6. 1.3 Moclobemide Market by Application
  7. 1.3.1 Global Moclobemide Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Moclobemide Market Dynamics
  1. 2.1 Moclobemide Industry Trends
  2. 2.2 Moclobemide Industry Drivers
  3. 2.3 Moclobemide Industry Opportunities and Challenges
  4. 2.4 Moclobemide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Moclobemide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Moclobemide Revenue by Region
  3. 3.2.1 Global Moclobemide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Moclobemide Revenue by Region (2021-2026)
  5. 3.2.3 Global Moclobemide Revenue by Region (2027-2032)
  6. 3.2.4 Global Moclobemide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Moclobemide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Moclobemide Sales by Region
  9. 3.4.1 Global Moclobemide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Moclobemide Sales by Region (2021-2026)
  11. 3.4.3 Global Moclobemide Sales by Region (2027-2032)
  12. 3.4.4 Global Moclobemide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Moclobemide Revenue by Manufacturers
  2. 4.1.1 Global Moclobemide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Moclobemide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Moclobemide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Moclobemide Sales by Manufacturers
  6. 4.2.1 Global Moclobemide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Moclobemide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Moclobemide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Moclobemide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Moclobemide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Moclobemide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Moclobemide Manufacturers, Product Type & Application
  13. 4.7 Global Moclobemide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Moclobemide Market CR5 and HHI
  16. 4.8.2 2025 Moclobemide Tier 1, Tier 2, and Tier 3
5 Moclobemide Market by Type
  1. 5.1 Global Moclobemide Revenue by Type
  2. 5.1.1 Global Moclobemide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Moclobemide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Moclobemide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Moclobemide Sales by Type
  6. 5.2.1 Global Moclobemide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Moclobemide Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Moclobemide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Moclobemide Price by Type
6 Moclobemide Market by Application
  1. 6.1 Global Moclobemide Revenue by Application
  2. 6.1.1 Global Moclobemide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Moclobemide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Moclobemide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Moclobemide Sales by Application
  6. 6.2.1 Global Moclobemide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Moclobemide Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Moclobemide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Moclobemide Price by Application
7 Company Profiles
  1. 7.1 Sandoz
  2. 7.1.1 Sandoz Company Information
  3. 7.1.2 Sandoz Business Overview
  4. 7.1.3 Sandoz Moclobemide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sandoz Moclobemide Product Portfolio
  6. 7.1.5 Sandoz Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Moclobemide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Roche Moclobemide Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 Lunan Pharmaceutical
  14. 7.3.1 Lunan Pharmaceutical Company Information
  15. 7.3.2 Lunan Pharmaceutical Business Overview
  16. 7.3.3 Lunan Pharmaceutical Moclobemide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lunan Pharmaceutical Moclobemide Product Portfolio
  18. 7.3.5 Lunan Pharmaceutical Recent Developments
  19. 7.4 Viatris
  20. 7.4.1 Viatris Company Information
  21. 7.4.2 Viatris Business Overview
  22. 7.4.3 Viatris Moclobemide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Viatris Moclobemide Product Portfolio
  24. 7.4.5 Viatris Recent Developments
  25. 7.5 Arrow Pharmaceuticals
  26. 7.5.1 Arrow Pharmaceuticals Company Information
  27. 7.5.2 Arrow Pharmaceuticals Business Overview
  28. 7.5.3 Arrow Pharmaceuticals Moclobemide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Arrow Pharmaceuticals Moclobemide Product Portfolio
  30. 7.5.5 Arrow Pharmaceuticals Recent Developments
  31. 7.6 Apotex
  32. 7.6.1 Apotex Company Information
  33. 7.6.2 Apotex Business Overview
  34. 7.6.3 Apotex Moclobemide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Apotex Moclobemide Product Portfolio
  36. 7.6.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Moclobemide Market Size by Type
  2. 8.1.1 North America Moclobemide Revenue by Type (2021-2032)
  3. 8.1.2 North America Moclobemide Sales by Type (2021-2032)
  4. 8.1.3 North America Moclobemide Price by Type (2021-2032)
  5. 8.2 North America Moclobemide Market Size by Application
  6. 8.2.1 North America Moclobemide Revenue by Application (2021-2032)
  7. 8.2.2 North America Moclobemide Sales by Application (2021-2032)
  8. 8.2.3 North America Moclobemide Price by Application (2021-2032)
  9. 8.3 North America Moclobemide Market Size by Country
  10. 8.3.1 North America Moclobemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Moclobemide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Moclobemide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Moclobemide Market Size by Type
  2. 9.1.1 Europe Moclobemide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Moclobemide Sales by Type (2021-2032)
  4. 9.1.3 Europe Moclobemide Price by Type (2021-2032)
  5. 9.2 Europe Moclobemide Market Size by Application
  6. 9.2.1 Europe Moclobemide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Moclobemide Sales by Application (2021-2032)
  8. 9.2.3 Europe Moclobemide Price by Application (2021-2032)
  9. 9.3 Europe Moclobemide Market Size by Country
  10. 9.3.1 Europe Moclobemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Moclobemide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Moclobemide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Moclobemide Market Size by Type
  2. 10.1.1 China Moclobemide Revenue by Type (2021-2032)
  3. 10.1.2 China Moclobemide Sales by Type (2021-2032)
  4. 10.1.3 China Moclobemide Price by Type (2021-2032)
  5. 10.2 China Moclobemide Market Size by Application
  6. 10.2.1 China Moclobemide Revenue by Application (2021-2032)
  7. 10.2.2 China Moclobemide Sales by Application (2021-2032)
  8. 10.2.3 China Moclobemide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Moclobemide Market Size by Type
  2. 11.1.1 Asia Moclobemide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Moclobemide Sales by Type (2021-2032)
  4. 11.1.3 Asia Moclobemide Price by Type (2021-2032)
  5. 11.2 Asia Moclobemide Market Size by Application
  6. 11.2.1 Asia Moclobemide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Moclobemide Sales by Application (2021-2032)
  8. 11.2.3 Asia Moclobemide Price by Application (2021-2032)
  9. 11.3 Asia Moclobemide Market Size by Country
  10. 11.3.1 Asia Moclobemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Moclobemide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Moclobemide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Moclobemide Market Size by Type
  2. 12.1.1 SAMEA Moclobemide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Moclobemide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Moclobemide Price by Type (2021-2032)
  5. 12.2 SAMEA Moclobemide Market Size by Application
  6. 12.2.1 SAMEA Moclobemide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Moclobemide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Moclobemide Price by Application (2021-2032)
  9. 12.3 SAMEA Moclobemide Market Size by Country
  10. 12.3.1 SAMEA Moclobemide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Moclobemide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Moclobemide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Moclobemide Value Chain Analysis
  2. 13.1.1 Moclobemide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Moclobemide Production Mode & Process
  6. 13.2 Moclobemide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Moclobemide Distributors
  9. 13.2.3 Moclobemide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst